Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$36.71 - $44.15 $6,607 - $7,947
-180 Reduced 0.28%
64,220 $2.67 Million
Q1 2023

Apr 25, 2023

BUY
$36.81 - $48.12 $1.42 Million - $1.86 Million
38,630 Added 149.9%
64,400 $2.66 Million
Q4 2022

Feb 03, 2023

SELL
$35.68 - $44.71 $1.23 Million - $1.54 Million
-34,500 Reduced 57.24%
25,770 $1.06 Million
Q3 2022

Nov 07, 2022

SELL
$42.51 - $54.02 $75,455 - $95,885
-1,775 Reduced 2.86%
60,270 $2.64 Million
Q2 2022

Jul 28, 2022

BUY
$46.84 - $59.75 $51,383 - $65,545
1,097 Added 1.8%
62,045 $3.05 Million
Q1 2022

May 12, 2022

BUY
$48.09 - $57.79 $241,796 - $290,568
5,028 Added 8.99%
60,948 $3.46 Million
Q4 2021

Jan 31, 2022

BUY
$47.19 - $62.68 $103,818 - $137,896
2,200 Added 4.1%
55,920 $2.94 Million
Q3 2021

Nov 15, 2021

BUY
$56.91 - $67.81 $45,243 - $53,908
795 Added 1.5%
53,720 $3.22 Million
Q2 2021

Aug 10, 2021

BUY
$64.02 - $71.72 $20,166 - $22,591
315 Added 0.6%
52,925 $3.59 Million
Q1 2021

May 07, 2021

BUY
$53.26 - $68.08 $2.8 Million - $3.58 Million
52,610 New
52,610 $3.45 Million
Q3 2017

Nov 08, 2017

SELL
$53.54 - $68.0 $42,832 - $54,400
-800 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
800
800 $0

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.